MedTech & Biopharma Device CMO/CDMO Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-06-26　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 110,227.2 Mn
2033 年預估規模: USD 271,758.5 Mn
年複合成長率 CAGR: 13.8%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type (Drug-Device Combination Products, Medical Devices, Diagnostics and Laboratory Devices/Equipment, and Other Product / Device Types), By Service Type (Design Development and Engineering Services, Contract manufacturing, Supply Chain Management, Quality and Regulations, and Other Value-Added Services), By Device Class (Class I, Class II, and Class III), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global MedTech & biopharma device CMO/CDMO market is estimated to be valued at USD 110,227.2 Mn in 2026 and is expected to reach USD 271,758.5 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033. The global MedTech & biopharma device CMO/CDMO market includes contract development and manufacturing services for medical devices, diagnostics, drug-device combination products, and drug delivery devices with high growth and innovation, as well as contract development and manufacturing services for devices and medical and healthcare applications. By functioning as outsourcing partners, CMOs/CDMOs help client companies design, engineer, provide and integrate regulatory, manufacturing, packaging and logistics. The need to control operational and product development expenses, speed product to market, gain market access for new innovative products and leverage specialized know how is encouraging pharmaceutical, medical device, and biopharmaceutical industries to seek an outsourced product design, development and manufacturing partner solution. Increased usage of autoinjector devices and biologics delivery devices, wearable medicals devices, and associated healthcare devices will require partnerships with strategically positioned CMOs/CDMOs throughout the life science industry, including drug development and delivery device and drug device combinations. Market Dynamics The global MedTech & biopharma device CMO/CDMO market is driven by the rising level of outsourcing of device development and manufacturing functions. Adoption of drug device combination products, biologics delivery devices and connected devices for medtech devices is promoting life sciences players to attain CMO/CDMO competency to optimize time-to-market, manufacturing and cost efficiency. However, a number of constraints are present in the market, such as stringent regulatory barriers, tedious validation process, and high-quality protection cost. These market limitations coupled with the bottlenecks in the supply chain and the limited capacity for niche manufacturing services pose hurdles to the market advancement. Nevertheless, increasing adoption of innovative drug delivery devices and wearable healthcare technologies as well as shift toward strategic outsourcing by emerging life sciences organizations will offer new opportunities for growth in MedTech & biopharma device CMO/CDMO market. Key Features of the Study • This report provides in-depth analysis of the global MedTech & biopharma device CMO/CDMO market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global MedTech & biopharma device CMO/CDMO market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Integer Holdings Corporation, Jabil Inc., Flex Ltd., Sanmina Corporation, Phillips-Medisize, Nordson MEDICAL, West Pharmaceutical Services, Gerresheimer AG, SteriPack Group, and Nipro Corporation • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global MedTech & biopharma device CMO/CDMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global MedTech & biopharma device CMO/CDMO market Market Segmentation • Product/Device Type Insights (Revenue, USD Mn, 2021 - 2033) o Drug-Device Combination Products o Medical Devices o Diagnostics and Laboratory Devices/Equipment o Other Product / Device Types • Service Type Insights (Revenue, USD Mn, 2021 - 2033) o Design Development and Engineering Services o Contract manufacturing o Supply Chain Management o Quality and Regulations o Other Value-Added Services • Device Class Insights (Revenue, USD Mn, 2021 - 2033) o Class I o Class II o Class III • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Integer Holdings Corporation o Jabil Inc. o Flex Ltd. o Sanmina Corporation o Phillips-Medisize o Nordson MEDICAL o West Pharmaceutical Services o Gerresheimer AG o SteriPack Group o Nipro Corporation

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type  Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type  Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class  Global MedTech & Biopharma Device CMO/CDMO Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Drug-Device Combination Products  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Medical Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Diagnostics and Laboratory Devices/Equipment  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Other Product / Device Types  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Design Development and Engineering Services  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Contract manufacturing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Supply Chain Management  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Quality and Regulations  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Other Value-Added Services  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Class I  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Class II  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Class III  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global MedTech & Biopharma Device CMO/CDMO Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 8. Competitive Landscape o Integer Holdings Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Jabil Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Flex Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sanmina Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Phillips-Medisize  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Nordson MEDICAL  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o West Pharmaceutical Services  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Gerresheimer AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o SteriPack Group  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Nipro Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 9. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘MedTech & Biopharma Device CMO/CDMO Market' - Global forecast to 2033

提及公司

Integer Holdings CorporationJabil Inc.Flex Ltd.Sanmina CorporationPhillips-MedisizeNordson MEDICALWest Pharmaceutical ServicesGerresheimer AGSteriPack GroupNipro Corporation

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們